Showing results (101-110 of 109) with videos related to
Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Cancer Research Communications|September 15, 2025
Immune Activation Signatures Associated with Fatigue in Cancer Patients Undergoing Immune Checkpoint Inhibitor TherapyHoward L Li, Soren Charmsaz, Mari Nakazawa, et al.Journal for Immunotherapy of Cancer|November 28, 2025
International real-world study of combination immunotherapy sequences in metastatic melanomaMora Guardamagna, Sarah E Lochrin, James William Smithy, et al.Cancer Immunology Research|January 11, 2022
Tumor MHC Class I Expression Associates with Intralesional IL2 Response in MelanomaMaryam Pourmaleki, Caitlin J Jones, Charlotte E Ariyan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2019
Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line TherapyPaul Nghiem, Shailender Bhatia, Evan J Lipson, et al.The New England Journal of Medicine|April 20, 2016
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell CarcinomaPaul T Nghiem, Shailender Bhatia, Evan J Lipson, et al.Science (New York, N.Y.)|June 11, 2021
Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockadeSneha Berry, Nicolas A Giraldo, Benjamin F Green, et al.The Journal of Clinical Investigation|October 15, 2024
Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signaturesChester J Kao, Soren Charmsaz, Stephanie L Alden, et al.Cancers|January 10, 2026
Metastatic Uveal Melanoma Surveillance: A Delphi Panel ConsensusJuan Alban, R Christopher Bowen, David A Reichstein, et al.Science Translational Medicine|February 21, 2014
Detection of circulating tumor DNA in early- and late-stage human malignanciesChetan Bettegowda, Mark Sausen, Rebecca J Leary, et al.Pageof 11